Journal of Infection and Chemotherapy最新文献

筛选
英文 中文
Delayed Candida glabrata-associated infected thoracic aortic aneurysm after candidemia supported by identical serial MLVA profiles: a case report. 延迟念珠菌相关的感染胸主动脉瘤后念珠菌支持相同系列MLVA档案:一个病例报告。
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-11-13 DOI: 10.1016/j.jiac.2026.103124
Ryota Takao, Naoki Iwanaga, Shun Nakaji, Tatsuro Hirayama, Satoru Koga, Yuya Ito, Nobuyuki Ashizawa, Kazuaki Takeda, Shotaro Ide, Naoki Hosogaya, Takahiro Takazono, Takeshi Tanaka, Takashi Miura, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae
{"title":"Delayed Candida glabrata-associated infected thoracic aortic aneurysm after candidemia supported by identical serial MLVA profiles: a case report.","authors":"Ryota Takao, Naoki Iwanaga, Shun Nakaji, Tatsuro Hirayama, Satoru Koga, Yuya Ito, Nobuyuki Ashizawa, Kazuaki Takeda, Shotaro Ide, Naoki Hosogaya, Takahiro Takazono, Takeshi Tanaka, Takashi Miura, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae","doi":"10.1016/j.jiac.2026.103124","DOIUrl":"10.1016/j.jiac.2026.103124","url":null,"abstract":"<p><p>Candida-associated infected aortic aneurysms (AAs) are exceptionally rare and frequently fatal. A 76-year-old man developed Candida glabrata candidemia after surgery for ascending colon cancer; the postoperative course was complicated by an anastomotic leak and intra-abdominal infection. Echinocandin therapy was discontinued because of profound neutropenia after 12 days of treatment, following negative blood cultures. Approximately 1 year later, an enlarging descending thoracic AA was detected and treated with thoracic endovascular aortic repair (TEVAR). Despite initially negative blood cultures, a normal or only minimally elevated serum β-D-glucan concentration, and negative Candida antigen testing, the aneurysm subsequently enlarged and required repeat TEVAR. Periaortic soft-tissue changes transiently regressed, further obscuring the diagnosis. Three months after the second TEVAR, computed tomography revealed renewed aneurysm enlargement and perigraft gas. C. glabrata was recovered from one of five blood culture sets. On the fifth day of admission, the patient experienced abrupt circulatory collapse with hemoptysis and died, likely due to aneurysm rupture through an aortobronchial fistula. All available intra-abdominal and bloodstream isolates of C. glabrata obtained throughout the clinical course had identical six-locus multiple-locus variable-number tandem-repeat analysis (MLVA) profiles. A prior episode of candidemia remains clinically relevant when a new or progressive aortic lesion develops, even after prolonged culture negativity. Serial aneurysm enlargement, periaortic inflammation, and delayed perigraft gas should outweigh apparently reassuring blood cultures or fungal biomarkers and should prompt early multidisciplinary reassessment, pursuit of tissue diagnosis when feasible, source control, and prolonged antifungal therapy.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"103124"},"PeriodicalIF":1.7,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-mimicking brain parenchymal granuloma with molecular detection of Mycobacterium xenopi by metagenomic sequencing and targeted PCR: a case report. 利用宏基因组测序和靶向PCR技术检测异种分枝杆菌分子的模拟肿瘤脑实质肉芽肿1例。
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-11-10 DOI: 10.1016/j.jiac.2026.103121
Yong Luo, Jian Chen, Fei Ye, Manling Zhang, Ying Zhang, Zhenxiang Zhan, Yihong He, Zeyu Zhu
{"title":"Tumor-mimicking brain parenchymal granuloma with molecular detection of Mycobacterium xenopi by metagenomic sequencing and targeted PCR: a case report.","authors":"Yong Luo, Jian Chen, Fei Ye, Manling Zhang, Ying Zhang, Zhenxiang Zhan, Yihong He, Zeyu Zhu","doi":"10.1016/j.jiac.2026.103121","DOIUrl":"10.1016/j.jiac.2026.103121","url":null,"abstract":"<p><p>Central nervous system infection caused by Mycobacterium xenopi is exceptionally rare and may mimic intracranial neoplasia. A 60-year-old woman with poorly controlled diabetes presented with progressive headache and left homonymous hemianopia. Magnetic resonance imaging showed an irregularly enhancing right occipital mass-like lesion with marked edema and tumor-like magnetic resonance spectroscopy. Stereotactic biopsy demonstrated chronic granulomatous inflammation without neoplasia; periodic acid-Schiff, Gomori methenamine silver, and acid-fast stains were negative. Metagenomic next-generation sequencing of sterile, unfixed lesional brain tissue detected 2347 species-specific reads assigned to M. xenopi, with a negative laboratory control. Targeted mycobacterial PCR performed during the diagnostic work-up on remaining biopsy-derived brain tissue was also reported positive for M. xenopi, providing concordant molecular support. Because tissue was limited, no separate specimen was submitted for culture or susceptibility testing. The patient received oral rifampicin, ethambutol, clarithromycin, and moxifloxacin. Headache resolved within 2 weeks, bedside visual-field assessment suggested partial improvement, and available records documented treatment for more than 6 months without clinically apparent adverse events. One-year non-contrast computed tomography showed right occipital encephalomalacic evolution without an obvious persistent mass-like lesion or mass effect. This case highlights the value of tissue-based molecular testing in tumor-mimicking central nervous system granulomas when conventional staining is nondiagnostic, while underscoring the continuing importance of culture, susceptibility testing, and prolonged objective follow-up.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"103121"},"PeriodicalIF":1.7,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149386792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imported melioidosis with septic shock in a short-term visitor from Cambodia to Japan: a case report and literature review of imported cases in Japan. 柬埔寨短期访日输入性类鼻疽并感染性休克1例:日本输入病例报告及文献复习
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-11-09 DOI: 10.1016/j.jiac.2026.103123
Yushi Shinozaki, Ryota Hase, Saya Ikegami, Mana Yamashiro, Kimihito Hirose, Donghwa Fujiwara, Tokisada Kano, Mutsuka Kurihara, Emiri Muranaka, Atsuko Horino, Shigetarou Mori, Daiki Saito
{"title":"Imported melioidosis with septic shock in a short-term visitor from Cambodia to Japan: a case report and literature review of imported cases in Japan.","authors":"Yushi Shinozaki, Ryota Hase, Saya Ikegami, Mana Yamashiro, Kimihito Hirose, Donghwa Fujiwara, Tokisada Kano, Mutsuka Kurihara, Emiri Muranaka, Atsuko Horino, Shigetarou Mori, Daiki Saito","doi":"10.1016/j.jiac.2026.103123","DOIUrl":"10.1016/j.jiac.2026.103123","url":null,"abstract":"<p><p>Melioidosis is a potentially fatal infectious disease caused by Burkholderia pseudomallei, a soil-dwelling Gram-negative bacterium endemic to Southeast Asia and northern Australia; however, it remains a rare imported disease in Japan. Here, we report a case of melioidosis in a 70-year-old Cambodian man who developed septic shock during a short-term visit to Japan. We also performed a literature review of all reported cases of imported melioidosis in Japan. The patient presented with a three-day history of abdominal pain and diarrhea. He was immunocompromised and was receiving prednisolone and tocilizumab for adult-onset Still's disease. Blood cultures obtained on admission revealed Gram-negative rods. The organism was initially identified as Burkholderia thailandensis by MALDI-TOF mass spectrometry but was later confirmed to be B. pseudomallei at the reference laboratory. The patient developed septic shock but recovered with intensive supportive care and antimicrobial therapy consisting of meropenem and trimethoprim-sulfamethoxazole. This case and our literature review highlight that, even in non-endemic countries, melioidosis should be included in the differential diagnosis in patients with a history of travel to, or residence in, endemic regions, and that prompt diagnosis and timely initiation of appropriate treatment are essential.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"103123"},"PeriodicalIF":1.7,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of empyema caused by Streptococcus agalactiae serotype V. 戊型无乳链球菌致脓胸1例。
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-11-09 DOI: 10.1016/j.jiac.2026.103122
Kei Mitani, Shigeki Kakuno, Waki Imoto, Kazuya Kishimoto, Kantaro Hara, Miku Ando, Minami Murakawa, Naomi Takayama, Masashi Ogawa, Hirofumi Ohtaki, Makoto Niki, Junichi Soh, Hiroshi Kakeya
{"title":"A rare case of empyema caused by Streptococcus agalactiae serotype V.","authors":"Kei Mitani, Shigeki Kakuno, Waki Imoto, Kazuya Kishimoto, Kantaro Hara, Miku Ando, Minami Murakawa, Naomi Takayama, Masashi Ogawa, Hirofumi Ohtaki, Makoto Niki, Junichi Soh, Hiroshi Kakeya","doi":"10.1016/j.jiac.2026.103122","DOIUrl":"https://doi.org/10.1016/j.jiac.2026.103122","url":null,"abstract":"<p><p>Group B Streptococcus (GBS) is a well-known causative pathogen of neonatal and maternal infections; however, empyema due to GBS in adults is rare. Invasive GBS infections are more likely to be severe, particularly in older patients or those with underlying diseases or immunocompromised status. We report a patient with empyema caused by Streptococcus agalactiae in an 80-year-old man with a history of lung malignancy. During routine follow-up after lung adenocarcinoma surgery, the patient showed increased sputum production, and chest computed tomography revealed an increase in encapsulated pleural effusion in the left thorax. Diagnostic thoracentesis yielded purulent pleural fluid, leading to the diagnosis of empyema. Pleural fluid culture revealed the presence of GBS. Therefore, the patient underwent chest drainage and received antimicrobial therapy. Although temporary clinical deterioration was observed, a favorable clinical course was achieved after surgical intervention. The isolated strain was identified as serotype V, which is one of the most frequently identified serotypes among invasive GBS isolates from nonpregnant adults. In patients at high risk of developing severe disease, early diagnosis and prompt intervention, including surgery, are essential.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"103122"},"PeriodicalIF":1.7,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficult-to-Treat Resistant Pseudomonas aeruginosa: Resistance Mechanisms and Susceptibility to the Novel Antipseudomonal β-Lactams. 难以治疗的耐药铜绿假单胞菌:对新型抗假单胞菌β-内酰胺的耐药机制和敏感性。
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-11-06 DOI: 10.1016/j.jiac.2026.103120
Yukihiro Kaneko, Hideki Kawamura, Koichi Yamada, Norihito Kaku, Katsunori Yanagihara
{"title":"Difficult-to-Treat Resistant Pseudomonas aeruginosa: Resistance Mechanisms and Susceptibility to the Novel Antipseudomonal β-Lactams.","authors":"Yukihiro Kaneko, Hideki Kawamura, Koichi Yamada, Norihito Kaku, Katsunori Yanagihara","doi":"10.1016/j.jiac.2026.103120","DOIUrl":"https://doi.org/10.1016/j.jiac.2026.103120","url":null,"abstract":"<p><p>Pseudomonas aeruginosa is an intrinsically resistant, opportunistic Gram-negative pathogen and a major cause of healthcare-associated infection, with a marked ability to acquire further resistance during therapy. Multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) classifications are widely used but may poorly reflect treatment difficulty, since resistant isolates may remain susceptible to other effective agents. The difficult-to-treat resistance (DTR) framework identifies non-susceptibility to a clinically relevant set of first-line agents and provides a more treatment-focused phenotypic classification; it has been adopted by Infectious Diseases Society of America (IDSA) and by the new Japanese Society of Chemotherapy/Japanese Association for Infectious Diseases (JSC/JAID) guidance, although it remains underrecognized in Japan. Four novel antipseudomonal β-lactams are now available for DTR P. aeruginosa (DTR-P): ceftolozane/tazobactam, ceftazidime/avibactam, imipenem/relebactam, and cefiderocol. The 2026 JSC/JAID guidance incorporates underlying resistance mechanisms into its approach to selecting among these agents. This review examines the evidence linking individual resistance mechanisms to expected in vitro susceptibility, emphasizing the heterogeneity of DTR isolates and the importance of direct susceptibility testing. We also summarize current epidemiology in Japan, where carbapenemase-producing isolates remain uncommon and chromosomal mechanisms predominate, and contrast this with regional differences worldwide. We then examine the practical challenges of mechanism-based antimicrobial selection, including limited access to mechanism testing and the frequent coexistence of resistance mechanisms. Finally, we review clinical outcome evidence for the four agents, noting broadly comparable efficacy across available studies but limited direct comparative evidence and no prospective evidence establishing that mechanism-guided selection improves clinical outcomes over conventional approaches in DTR-P infections.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"103120"},"PeriodicalIF":1.7,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149357547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A nomogram for predicting in-hospital mortality in patients with coagulase-negative staphylococcus bloodstream infections 预测凝固酶阴性葡萄球菌血流感染患者住院死亡率的nomogram。
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-11-01 Epub Date: 2026-10-22 DOI: 10.1016/j.jiac.2026.103111
Junjin Liu, Liang Gao, Qichao Fan, Si Chen, Zhen Lin, Jin Cao, Haibo Ding, Yuekai Hu
{"title":"A nomogram for predicting in-hospital mortality in patients with coagulase-negative staphylococcus bloodstream infections","authors":"Junjin Liu,&nbsp;Liang Gao,&nbsp;Qichao Fan,&nbsp;Si Chen,&nbsp;Zhen Lin,&nbsp;Jin Cao,&nbsp;Haibo Ding,&nbsp;Yuekai Hu","doi":"10.1016/j.jiac.2026.103111","DOIUrl":"10.1016/j.jiac.2026.103111","url":null,"abstract":"<div><h3>Introduction</h3><div>Coagulase-negative staphylococci (CoNS) have emerged as significant pathogens in bloodstream infections (BSIs). Currently, no validated models exist for specifically predicting in-hospital mortality in patients with CoNS-BSIs.</div></div><div><h3>Methods</h3><div>A retrospective study was conducted on adult patients with CoNS-BSIs using the Medical Information Mart for Intensive Care (MIMIC-III) database. Participants were randomly allocated into a training set (n = 366) and a validation set (n = 157). Demographic characteristics, severity scores, comorbidities and laboratory examinations from the first 24 h of ICU admission were analyzed. The optimal predictive variables for establishing a nomogram were screened through univariate, multivariate logistic regression and stepwise regression analyses. Model performance was evaluated by receiver operator characteristic (ROC) curve, calibration curve, decision curve analysis (DCA) and clinical impact curve (CIC).</div></div><div><h3>Results</h3><div>Among 523 patients enrolled, the overall in-hospital mortality was 22.9%. Four independent predictors were incorporated into the nomogram: age (OR = 1.04), anion gap (AG: OR = 1.11), total bilirubin (TBil: OR = 1.26) and respiratory failure (OR = 1.97). The area under the curve (AUC) values in the training set and validation set were 0.758 and 0.823, respectively. The <em>P</em>-values of the calibration curve in two sets were 0.258 and 0.432. The DCA curves were above the two extreme curves. The CIC analysis revealed a high concordance between predicted high-risk cases and observed clinical events when the risk threshold exceeded 60%.</div></div><div><h3>Conclusion</h3><div>Age, AG, TBil and respiratory failure were independent risk factors for in-hospital mortality among patients with CoNS-BSIs. The nomogram based on these four parameters demonstrated good performance and clinical utility for risk assessment.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 11","pages":"Article 103111"},"PeriodicalIF":1.7,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological characteristics of pertussis in Hainan Province, 2023-2025. 2023-2025年海南省百日咳流行病学特征
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-10-20 DOI: 10.1016/j.jiac.2026.103105
Wenli Li, Yajing Huang, Changrong Guan, Zhenwang Fu, Xuexia Zeng
{"title":"Epidemiological characteristics of pertussis in Hainan Province, 2023-2025.","authors":"Wenli Li, Yajing Huang, Changrong Guan, Zhenwang Fu, Xuexia Zeng","doi":"10.1016/j.jiac.2026.103105","DOIUrl":"10.1016/j.jiac.2026.103105","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the epidemiological characteristics of pertussis in Hainan Province from 2023 to 2025, describe the outbreak trajectory and patterns of population susceptibility, and provide evidence for optimizing pertussis prevention and control strategies.</p><p><strong>Methods: </strong>Clinically diagnosed and confirmed pertussis cases reported in Hainan Province between January 1, 2023, and December 31, 2025, were retrieved from the China Information System for Disease Control and Prevention; suspected cases were excluded, yielding a total of 2927 eligible cases.Descriptive epidemiological methods were used to analyze the temporal, geographic, and population distributions of the cases; piecewise linear regression was employed to characterize monthly trends in case counts; and multivariable logistic regression was performed to identify risk factors for hospitalization.</p><p><strong>Results: </strong>The incidence of pertussis in Hainan Province exhibited an outbreak-and-decline pattern from 2023 to 2025, increasing from 4.29 per 100,000 population in 2023 to 22.26 per 100,000 in 2024 before declining to 1.37 per 100,000 in 2025, with a statistically significant difference across the three years (χ<sup>2</sup> = 2888.2, P < 0.001).Piecewise linear regression showed that the monthly number of cases increased significantly during the ascending phase (β = 21.82, P < 0.001) and decreased significantly during the descending phase (β = -11.41, P < 0.001).The age distribution shifted significantly toward older children: the proportion of infants aged <1 year decreased from 43.1% to 27.3%, whereas that of individuals aged ≥1 year increased from 56.9% to 72.7%.Among cases with complete severity records after July 2024, infants aged 0-2 months had the highest risk of hospitalization and accounted for 90.0% of intensive care unit admissions.</p><p><strong>Conclusion: </strong>This study shows that the 2024 pertussis outbreak in Hainan was followed by a rapid decline in 2025, with a shift toward older children and a persistently high hospitalization risk in infants aged 0-2 months. These findings support strengthening surveillance in schools and childcare institutions and evaluating the effectiveness of the 6-year DTaP booster policy, while maintaining maternal and infant protection strategies.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"103105"},"PeriodicalIF":1.7,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149228026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0. 使用实用抗菌治疗药物监测(PAT) 4.0版本对万古霉素在体重指数类别中的单槽贝叶斯估计的预测性能
IF 1.7 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-10-01 DOI: 10.1016/j.jiac.2026.103089
Kaori Arai, Kengo Ohashi, Yasutaka Shinoda, Nao Hotta, Tomoko Matsuoka, Reiko Yano, Eiseki Usami
{"title":"Predictive performance of single-trough Bayesian estimation for vancomycin across body mass index categories using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0.","authors":"Kaori Arai, Kengo Ohashi, Yasutaka Shinoda, Nao Hotta, Tomoko Matsuoka, Reiko Yano, Eiseki Usami","doi":"10.1016/j.jiac.2026.103089","DOIUrl":"https://doi.org/10.1016/j.jiac.2026.103089","url":null,"abstract":"<p><strong>Background: </strong>This study evaluated whether body mass index (BMI) affects the predictive performance of single-trough Bayesian estimation for vancomycin (VCM) using Practical Antimicrobial Therapeutic Drug Monitoring (PAT) version 4.0.</p><p><strong>Methods: </strong>This retrospective single-center study included adult patients who received VCM between April 2020 and March 2023 with at least two trough concentrations measured. Patients were categorized as underweight (BMI <18.5 kg/m<sup>2</sup>), normal-weight (18.5 ≤ BMI <25 kg/m<sup>2</sup>), or overweight (BMI ≥25 kg/m<sup>2</sup>). Using posterior parameters from the initial therapeutic drug monitoring (TDM) assessment, the second trough was predicted and compared with the observed value. Predictive performance was assessed by mean prediction error (ME), mean absolute error (MAE), and Spearman's rank correlation. Prediction deviation was defined as an observed-to-predicted ratio outside 0.8-1.2; associated factors were identified by logistic regression. Sensitivity analyses used continuous BMI, restriction to patients with stable renal function, and ΔSCr instead of ΔCLcr.</p><p><strong>Results: </strong>Among 190 patients (45 underweight, 101 normal-weight, 44 overweight), BMI ranged from 14.2 to 49.3 kg/m<sup>2</sup>, with 18 patients ≥30 kg/m<sup>2</sup> and 7 ≥35 kg/m<sup>2</sup>. ME and MAE did not differ among BMI groups; correlation coefficients were 0.595, 0.617, and 0.711. Overall, 37.4% showed prediction deviation. Deviation was associated with variation in renal function, but not with BMI category, and this pattern persisted in sensitivity analyses.</p><p><strong>Conclusions: </strong>In this cohort, BMI did not significantly affect the predictive performance of single-trough Bayesian estimation. Clinically relevant deviations occurred in approximately one-third of patients, indicating limitations of single-trough prediction, particularly when renal function is unstable.</p>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":" ","pages":"103089"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149110550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical pharmacist-led implementation of an intravenous-to-oral antimicrobial switch protocol: A prospective Quasi-experimental study 临床药师主导的静脉到口服抗菌药物切换方案的实施:一项前瞻性准实验研究。
IF 1.5 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-03-01 Epub Date: 2026-02-06 DOI: 10.1016/j.jiac.2026.102925
Fatma Gul Yumrucu , Emre Kara , Leyla Yumrukaya , Hatice Yagmur Zengin , Selen Yegenoglu , Ahmet Cagkan Inkaya , Gokhan Metan , Omrum Uzun
{"title":"Clinical pharmacist-led implementation of an intravenous-to-oral antimicrobial switch protocol: A prospective Quasi-experimental study","authors":"Fatma Gul Yumrucu ,&nbsp;Emre Kara ,&nbsp;Leyla Yumrukaya ,&nbsp;Hatice Yagmur Zengin ,&nbsp;Selen Yegenoglu ,&nbsp;Ahmet Cagkan Inkaya ,&nbsp;Gokhan Metan ,&nbsp;Omrum Uzun","doi":"10.1016/j.jiac.2026.102925","DOIUrl":"10.1016/j.jiac.2026.102925","url":null,"abstract":"<div><h3>Objectives</h3><div>In antimicrobial therapy, early intravenous-to-oral switch (IVOS) is recommended for eligible patients to minimize complications and optimize pharmacoeconomic outcomes. This study aimed to evaluate the impact of a clinical pharmacist-led multimodal intervention strategy on IVOS rates.</div></div><div><h3>Methods</h3><div>A prospective before-and-after study was conducted between January and June 2024, including observation and intervention periods. Hospitalized adults receiving IV antimicrobials were included. A two-round expert panel was convened prior to data collection to identify the criteria for IVOS. During the observation period, IV antimicrobial utilization patterns were monitored without intervention. The intervention period involved the implementation of a standardized IVOS protocol, targeted education for infectious disease physicians, and switch recommendations for eligible treatments. The primary endpoint was the difference in IVOS rates between study periods among eligible treatments.</div></div><div><h3>Results</h3><div>Among 962 IV antimicrobial courses evaluated, 213 (22.1%) met the eligibility criteria for IVOS. Among patients who met IVOS eligibility criteria, the proportion undergoing overall IVOS increased from 29.0% in the observation period to 54.0% in the intervention period (p &lt; 0.001). Among 113 IVOS-eligible cases, pharmacists recommended switching in 57 (50.4%), with a 59.6% physician acceptance rate (34/57). No significant differences were observed between periods for: microbiological cure rates, <em>Clostridioides difficile</em> infection incidence, intensive care unit admission rates, antimicrobial reinitiation within 48 h of treatment cessation, 15- and 30-day readmission and mortality rates. Antimicrobial costs decreased significantly from $15,600.30 (all-parenteral baseline) and $14,997.40 (adjusted baseline) to $8333.81 post intervention.</div></div><div><h3>Conclusions</h3><div>The intervention was associated with a substantial increase in overall IVOS among eligible patients, supporting its effectiveness in promoting timely de-escalation from intravenous therapy. Clinical pharmacist-led initiatives optimize appropriate switching and antimicrobial utilization in stewardship.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 3","pages":"Article 102925"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146142513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of recombinant human thrombomodulin in a pediatric case of COVID-19–associated coagulopathy: A case report 重组人血栓调节蛋白在小儿covid -19相关凝血病中的应用:1例报告
IF 1.5 4区 医学
Journal of Infection and Chemotherapy Pub Date : 2026-03-01 Epub Date: 2026-02-09 DOI: 10.1016/j.jiac.2026.102926
Fumihiro Ochi , Kozo Nagai , Shiori Ukita , Ayuko Yoshida , Mika Kawabe , Tomozo Moritani , Naoko Nakano , Eiichi Yamamoto , Hisamichi Tauchi
{"title":"Use of recombinant human thrombomodulin in a pediatric case of COVID-19–associated coagulopathy: A case report","authors":"Fumihiro Ochi ,&nbsp;Kozo Nagai ,&nbsp;Shiori Ukita ,&nbsp;Ayuko Yoshida ,&nbsp;Mika Kawabe ,&nbsp;Tomozo Moritani ,&nbsp;Naoko Nakano ,&nbsp;Eiichi Yamamoto ,&nbsp;Hisamichi Tauchi","doi":"10.1016/j.jiac.2026.102926","DOIUrl":"10.1016/j.jiac.2026.102926","url":null,"abstract":"<div><div>Coronavirus disease 2019 (COVID-19)–associated coagulopathy (CAC) is a known extrapulmonary complication of severe acute respiratory syndrome coronavirus 2 infection, primarily studied in adults. As a result, pediatric data are limited, and management strategies remain under investigation. Recombinant human soluble thrombomodulin (rh-TM), an anticoagulant with anti-inflammatory and antifibrinolytic properties, has shown promise in sepsis-induced coagulopathy; however, it has not been widely studied in children with CAC. A previously healthy 5-year-old girl presented with severe CAC secondary to COVID-19. She initially presented with persistent fever, gastrointestinal and respiratory symptoms, and gingival bleeding. Laboratory evaluation revealed significant coagulopathy characterized by high D-dimer (≥110.3 μg/mL), fibrinogen/fibrin degradation products (328.6 μg/mL), thrombin–antithrombin complex (≥120 ng/mL), and plasmin–α2 plasmin inhibitor complex (7.7 μg/mL), along with thrombocytopenia and prolonged prothrombin time and international normalized ratio and activated partial thromboplastin time. Imaging showed ground-glass opacities on chest computed tomography (CT) and increased <sup>18</sup>F-fluorodeoxyglucose uptake in positron emission tomography–CT. A multidisciplinary treatment regimen was initiated, including intravenous immunoglobulin, remdesivir, rh-TM, corticosteroids, low-dose aspirin, and budesonide inhalation. Levels of coagulation markers gradually normalized, and the patient's clinical symptoms resolved without further complications. She was discharged on day 29 of illness and remained relapse-free after 1 year of follow-up. This case highlights the potential utility of rh-TM as part of a tailored multimodal treatment strategy for pediatric CAC. Early recognition and individualized, stage-specific therapy may contribute to favorable outcomes. However, further studies are warranted to evaluate the safety and efficacy of rh-TM in children with CAC.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 3","pages":"Article 102926"},"PeriodicalIF":1.5,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书